These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36876767)

  • 1. α-D-1,3-glucan from Radix Puerariae thomsonii improves NAFLD by regulating the intestinal flora and metabolites.
    Li Q; Liu W; Zhang H; Chen C; Liu R; Hou H; Luo Q; Yu Q; Ouyang H; Feng Y; Zhu W
    Carbohydr Polym; 2023 Jan; 299():120197. PubMed ID: 36876767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radix Puerariae thomsonii polysaccharide (RPP) improves inflammation and lipid peroxidation in alcohol and high-fat diet mice by regulating gut microbiota.
    Li Q; Liu W; Feng Y; Hou H; Zhang Z; Yu Q; Zhou Y; Luo Q; Luo Y; Ouyang H; Zhang H; Zhu W
    Int J Biol Macromol; 2022 Jun; 209(Pt A):858-870. PubMed ID: 35439478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pharmacodynamics and intestinal flora research on different processed products of Puerariae Lobatae Radix and Puerariae Thomsonii Radix].
    Zhong LY; Deng XY; Huang Y; Liao JJ; Zhu WF; Yu H; Zhou SC; Chen RL
    Zhongguo Zhong Yao Za Zhi; 2021 Sep; 46(17):4403-4409. PubMed ID: 34581043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparison of sulfur fumigation processing and direct hot air heating technology on puerarin contents and efficacy of Puerariae Thomsonii Radix].
    Yu HL; Zhang Q; Jin YP; Wang KL; Lu TL; Li L
    Zhongguo Zhong Yao Za Zhi; 2016 Jul; 41(14):2571-2575. PubMed ID: 28905588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mussel polysaccharide α-D-glucan (MP-A) protects against non-alcoholic fatty liver disease via maintaining the homeostasis of gut microbiota and regulating related gut-liver axis signaling pathways.
    Wu J; Shao H; Zhang J; Ying Y; Cheng Y; Zhao D; Dou X; Lv H; Li S; Liu F; Ling P
    Int J Biol Macromol; 2019 Jun; 130():68-78. PubMed ID: 30797009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular authentication of Radix Puerariae Lobatae and Radix Puerariae Thomsonii by ITS and 5S rRNA spacer sequencing.
    Sun Y; Shaw PC; Fung KP
    Biol Pharm Bull; 2007 Jan; 30(1):173-5. PubMed ID: 17202681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing morphological, chemical and anti-diabetic characteristics of Puerariae Lobatae Radix and Puerariae Thomsonii Radix.
    Wong KH; Razmovski-Naumovski V; Li KM; Li GQ; Chan K
    J Ethnopharmacol; 2015 Apr; 164():53-63. PubMed ID: 25560667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics of the anti-inflammatory effect of Pueraria lobata and Pueraria lobata var. Thomsonii in rats.
    Xi C; Zhang M; Li B; Meng X; Xu S; Du H; Wang X; Xu J; Ke H; Cui Y; Qu F
    J Ethnopharmacol; 2023 Apr; 306():116144. PubMed ID: 36649849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-performance thin-layer chromatographic fingerprints of isoflavonoids for distinguishing between Radix Puerariae Lobate and Radix Puerariae Thomsonii.
    Chen SB; Liu HP; Tian RT; Yang DJ; Chen SL; Xu HX; Chan AS; Xie PS
    J Chromatogr A; 2006 Jul; 1121(1):114-9. PubMed ID: 16714027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Network pharmacology-based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver disease.
    Liu H; Xu J; Li H; Zhang L; Xu P
    Anat Rec (Hoboken); 2021 Nov; 304(11):2605-2619. PubMed ID: 34536264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating Puerariae Lobatae Radix and Puerariae Thomsonii Radix using HPTLC coupled with multivariate classification analyses.
    Wong KH; Razmovski-Naumovski V; Li KM; Li GQ; Chan K
    J Pharm Biomed Anal; 2014 Jul; 95():11-9. PubMed ID: 24631955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radix Puerariae: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use.
    Zhang Z; Lam TN; Zuo Z
    J Clin Pharmacol; 2013 Aug; 53(8):787-811. PubMed ID: 23677886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Astragalus mongholicus polysaccharides ameliorate hepatic lipid accumulation and inflammation as well as modulate gut microbiota in NAFLD rats.
    Zhong M; Yan Y; Yuan H; A R; Xu G; Cai F; Yang Y; Wang Y; Zhang W
    Food Funct; 2022 Jul; 13(13):7287-7301. PubMed ID: 35726797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of autophagy via the PI3K/Akt/mTOR signaling pathway by Pueraria flavonoids improves non-alcoholic fatty liver disease in obese mice.
    Sun C; Zhang J; Hou J; Hui M; Qi H; Lei T; Zhang X; Zhao L; Du H
    Biomed Pharmacother; 2023 Jan; 157():114005. PubMed ID: 36384052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gynostemma pentaphyllum saponins alleviate non-alcoholic fatty liver disease in rats by regulating intestinal flora and short-chain fatty acid metabolism].
    Zhong FW; Li GX; Zeng L
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(9):2500-2508. PubMed ID: 35531697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Zhishi Daozhi Decoction on the intestinal flora of nonalcoholic fatty liver disease mice induced by a high-fat diet.
    Bi CR; Sun JT; Du J; Chu LY; Li YJ; Jia XY; Liu Y; Zhang WP; Li YC; Liu YJ
    Front Cell Infect Microbiol; 2022; 12():1005318. PubMed ID: 36683694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astragaloside IV ameliorates diet-induced hepatic steatosis in obese mice by inhibiting intestinal FXR via intestinal flora remodeling.
    Zhai Y; Zhou W; Yan X; Qiao Y; Guan L; Zhang Z; Liu H; Jiang J; Liu J; Peng L
    Phytomedicine; 2022 Dec; 107():154444. PubMed ID: 36155217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of major chemical components in Puerariae Thomsonii Radix and Puerariae Lobatae Radix].
    Yue SY; Zhou RR; Nan TG; Huang LQ; Yuan Y
    Zhongguo Zhong Yao Za Zhi; 2022 May; 47(10):2689-2697. PubMed ID: 35718488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
    Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
    Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Nguyen HT; Gu M; Werlinger P; Cho JH; Cheng J; Suh JW
    Int J Mol Sci; 2022 Nov; 23(21):. PubMed ID: 36362221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.